Acute graft-versus-host disease (aGVHD) is a life-threatening complication after allogeneic hematopoietic stem cell ...
How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy cells? Research into an immune kill switch holds potential for controlling ...
Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...
Early evidence suggests safety, efficacy, while awaiting data on durability in broader pop ...
A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...
Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...
Inflammation has to fight pathogens fast—but it can't get out of control. Researchers at the German Cancer Research Center ...
A recent study by Vanderbilt Health researchers has revealed a greater, detrimental role for B lymphocytes (B cells) in the ...
Janux Therapeutics has partnered with Bristol Myers Squibb in a global licensing and collaboration deal to advance a ...
Findings from a phase I trial (NCT04183166) evaluating TG4050, a neoantigen therapeutic vaccine, in patients with operable, ...